- Home
- OSW vs WVE Comparison
OSW vs WVE Comparison
Compare OSW & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSW
- WVE
- Stock Information
- Founded
- OSW N/A
- WVE 2012
- Country
- OSW Bahamas
- WVE Singapore
- Employees
- OSW N/A
- WVE N/A
- Industry
- OSW Hotels/Resorts
- WVE Biotechnology: Pharmaceutical Preparations
- Sector
- OSW Consumer Discretionary
- WVE Health Care
- Exchange
- OSW Nasdaq
- WVE Nasdaq
- Market Cap
- OSW 2.0B
- WVE 2.4B
- IPO Year
- OSW N/A
- WVE 2015
- Fundamental
- Price
- OSW $19.10
- WVE $14.35
- Analyst Decision
- OSW Strong Buy
- WVE Strong Buy
- Analyst Count
- OSW 4
- WVE 10
- Target Price
- OSW $18.75
- WVE $21.30
- AVG Volume (30 Days)
- OSW 596.1K
- WVE 1.3M
- Earning Date
- OSW 10-30-2024
- WVE 11-12-2024
- Dividend Yield
- OSW 0.42%
- WVE N/A
- EPS Growth
- OSW 2284.58
- WVE N/A
- EPS
- OSW 0.50
- WVE N/A
- Revenue
- OSW $872,619,000.00
- WVE $53,610,000.00
- Revenue This Year
- OSW $13.37
- WVE N/A
- Revenue Next Year
- OSW $9.04
- WVE N/A
- P/E Ratio
- OSW $37.87
- WVE N/A
- Revenue Growth
- OSW 13.60
- WVE N/A
- 52 Week Low
- OSW $11.50
- WVE $3.50
- 52 Week High
- OSW $19.61
- WVE $16.74
- Technical
- Relative Strength Index (RSI)
- OSW 66.64
- WVE 54.93
- Support Level
- OSW $18.27
- WVE $12.66
- Resistance Level
- OSW $19.61
- WVE $16.71
- Average True Range (ATR)
- OSW 0.42
- WVE 1.14
- MACD
- OSW -0.03
- WVE -0.36
- Stochastic Oscillator
- OSW 76.61
- WVE 41.42
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts worldwide. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.